5:01 PM ET
8-K
Nasdaq/NYSE Compliance Notice
Propanc Biopharma Nasdaq/NYSE Compliance Notice
Propanc Biopharma received a delisting notice from Nasdaq on October 23, 2026, for failing to maintain the $1.00 minimum bid price requirement. Because the company already completed a reverse stock split within the past year, it is ineligible for the standard 180-day grace period and faces delisting on November 2, 2026. The company intends to appeal the determination to a hearings panel, which will stay the delisting process.
- Counterparty
- Nasdaq